Betz Stephen F. 5
5 · Crinetics Pharmaceuticals, Inc. · Filed Jan 29, 2025
Insider Transaction Report
Form 5
Betz Stephen F.
Chief Scientific Officer
Transactions
- Other
Common Stock
2024-11-20$14.98/sh+451$6,756→ 71,358 total
Footnotes (1)
- [F1]Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),